Related Experiment Video
Updated: May 5, 2026

09:53
Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
Published on: August 16, 2020
7.3K
Ultra-fast deep-learned CNS tumour classification during surgery
C Vermeulen1,2, M Pagès-Gallego1,2, L Kester3
1Oncode Institute, Utrecht, The Netherlands.
Nature
|October 11, 2023
Summary
A new AI tool, Sturgeon, accurately classifies central nervous system tumors during surgery using rapid sequencing. This machine-learned diagnosis aids neurosurgeons, potentially improving patient outcomes and reducing complications.
Area of Science:
- Neuro-oncology
- Artificial Intelligence in Medicine
- Genomic Medicine
Background:
- Central nervous system (CNS) tumors are highly lethal, especially in children.
- Neurosurgical tumor resection requires balancing maximal tumor removal with minimal neurological damage.
- Current diagnostic methods like imaging and histology are often inconclusive or inaccurate.
Purpose of the Study:
- To develop a patient-agnostic, transfer-learned neural network (Sturgeon) for molecular subclassification of CNS tumors.
- To enable rapid, intraoperative CNS tumor diagnosis using sparse methylation profiles from nanopore sequencing.
- To assess the accuracy and speed of Sturgeon in real-time surgical settings.
Main Methods:
- Development of Sturgeon, a neural network trained on sparse methylation profiles.
- Utilizing rapid nanopore sequencing for intraoperative data acquisition.
- Validation of Sturgeon on retrospective and real-time surgical cases.
Main Results:
- Sturgeon achieved accurate diagnoses in 45/50 retrospective samples within 40 minutes.
- In real-time surgeries, Sturgeon provided diagnoses in under 90 minutes.
- 72% (18/25) of real-time diagnoses were correct, with others not reaching confidence thresholds.
Conclusions:
- Machine-learned diagnosis via low-cost intraoperative sequencing can aid neurosurgical decision-making.
- This approach has the potential to prevent neurological comorbidity and avoid repeat surgeries.
- AI-powered molecular subclassification offers a promising advancement in CNS tumor management.

